Payal D. Shah

Rutgers, The State University of New Jersey

Also affiliated with Dartmouth–Hitchcock Medical Center, Hospital of the University of Pennsylvania, Dartmouth Psychiatric Research Center, Penn Center for AIDS Research, University of Pennsylvania Health System, Dartmouth Hospital, Abramson Cancer Center, Dartmouth Health, Rutgers New Jersey Medical School, University of Pennsylvania

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 18 papers. Top paper: “Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma”.

Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0486

N/A

2.2DataRank · unranked

95 citations

Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter +20 more

In vivo visualization of PARP inhibitor pharmacodynamics

JCI Insight(2021)10.1172/jci.insight.146592

N/A

1.1DataRank · unranked

32 citations

Austin R. Pantel, Payal D. Shah, Michael D. Farwell, Amy S. Clark, Robert K. Doot +3 more

Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2023.5424

N/A

0.911DataRank · unranked

34 citations

Vandana G. Abramson, Elizabeth Claire Dees, Payal D. Shah, Tarah J. Ballinger, Claudine Isaacs +12 more

Phase I trial of autologous cMET-directed CAR-t cells administered intravenously in patients with melanoma & breast carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10035

N/A

0.470DataRank · unranked

22 citations

Alexander C. Huang, Xiaowei Xu, Paul J. Zhang, Robert Orlowski, Tina Matlawski +15 more

Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.46201

N/A

0.208DataRank · unranked

3 citations

Amanda M. Smith, Bénédicte Lefebvre, Faizi Jamal, Saro H. Armenian, Daniel Koropeckyj-Cox +21 more

C ombination A TR (ceralasertib) and P A R P (olaparib) I nhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2444

N/A

0DataRank · unranked

79 citations

Payal D. Shah, Lainie P. Martin, János L. Tanyi, Nawar Latif, Mark A. Morgan +14 more

NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0519

N/A

0DataRank · unranked

65 citations

Xiaopeng Sun, Paula I. González-Ericsson, Violeta Sánchez, Melinda E. Sanders, Elizabeth C. Wescott +15 more

Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education

Journal of Clinical Oncology(2023)10.1200/jco.22.00516

N/A

0DataRank · unranked

11 citations

Brian L. Egleston, Wendy K. Chung, Olufunmilayo I. Olopade, Kara N. Maxwell, Payal D. Shah +24 more

Data from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T cells Administered Intravenously in Patients with Melanoma & Breast Carcinoma

(2023)10.1158/2767-9764.c.6547846.v1

N/A

0DataRank · unranked

0 citations

Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter +20 more

Data from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma

(2023)10.1158/2767-9764.c.6547846.v2

N/A

0DataRank · unranked

0 citations

Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter +20 more

The role of recovery peer navigators in retention in outpatient buprenorphine treatment: a retrospective cohort study

Annals of Medicine(2024)10.1080/07853890.2024.2355566

N/A

0DataRank · unranked

7 citations

Payal D. Shah, Erin Zerbo, Amesika N. Nyaku, Arley Giraldo

Cardiac Effects of Modern Breast Radiation Therapy in Patients Receiving Systemic Cancer Therapy

JACC CardioOncology(2025)10.1016/j.jaccao.2025.01.012

N/A

0DataRank · unranked

12 citations

Kyunga Ko, Lin Ma, Ian Messing, Casey Hollawell, Amanda M. Smith +19 more

Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa040

N/A

0DataRank · unranked

78 citations

Eric C. Polley, Chunling Hu, Esther M. John, Christopher A. Haiman, Steven N. Hart +27 more

Clinical trial protocol1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

10.1158/1078-0432.23814207.v1

N/A

0DataRank · unranked

0 citations

Payal D. Shah, Lainie P. Martin, János L. Tanyi, Nawar Latif, Mark A. Morgan +14 more

Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.08.024

N/A

0DataRank · unranked

117 citations

Stephanie L. Wethington, Cheyenne Pagan, Nawar Latif, János L. Tanyi, Lainie P. Martin +17 more

Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab

JACC Basic to Translational Science(2021)10.1016/j.jacbts.2021.10.010

N/A

0DataRank · unranked

14 citations

Biniyam G. Demissei, Amanda M. Smith, Priya Brahmbhatt, Jessica Wang, Amy S. Clark +10 more

EUS-based Pancreatic Cancer Surveillance in BRCA1/BRCA2/PALB2/ATM Carriers Without a Family History of Pancreatic Cancer

Cancer Prevention Research(2021)10.1158/1940-6207.capr-21-0161

N/A

0DataRank · unranked

10 citations

Jessica M. Long, Nuzhat A. Ahmad, Sara Attalla, Angela R. Bradbury, Erica L. Carpenter +16 more

BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors

Frontiers in Cardiovascular Medicine(2022)10.3389/fcvm.2022.833171

N/A

0DataRank · unranked

7 citations

Wenjian Lv, Nicholas S. Wilcox, Karyn Sheline, Amanda M. Smith, Kathleen M. Sturgeon +7 more